Trial Outcomes & Findings for Email Campaign to Increase Uptake of myGeisinger (NCT NCT04332614)

NCT ID: NCT04332614

Last Updated: 2021-05-03

Results Overview

Whether email was opened (yes / no)

• Recruitment status: COMPLETED
• Target enrollment: 14099 participants
• Primary outcome timeframe: 8-10 days post-intervention
• Results posted on: 2021-05-03

Participant Flow

Participant milestones

Measure	Control A standard marketing message encouraging activation and describing the benefits of myGeisinger Standard email: Email	Focused on Provider Communication A simple message focused on one benefit of myGeisinger: communicating easily with providers Less-is-better: Email	Focused on Scheduling A simple message focused on one benefit of myGeisinger: scheduling and managing appointments online Less-is-better: Email	Focused on Medical Information Access A simple message focused on one benefit of myGeisinger: accessing medical information, like test results Less-is-better: Email	Social Proof A message similar to control, but including information about how many other patients are using myGeisinger Social proof: Email	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete Endowment / decision staging: Email
~1 Week After Study Launch STARTED	2350	2350	2350	2350	2350	2349
~1 Week After Study Launch Data in EHR	2245	2273	2251	2254	2251	2249
~1 Week After Study Launch COMPLETED	2117	2129	2124	2131	2127	2115
~1 Week After Study Launch NOT COMPLETED	233	221	226	219	223	234
~1 Month After Study Launch STARTED	2117	2129	2124	2131	2127	2115
~1 Month After Study Launch COMPLETED	2095	2107	2094	2107	2107	2096
~1 Month After Study Launch NOT COMPLETED	22	22	30	24	20	19

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Measure	Control n=2350 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger Standard email: Email	Focused on Provider Communication n=2350 Participants A simple message focused on one benefit of myGeisinger: communicating easily with providers Less-is-better: Email	Focused on Scheduling n=2350 Participants A simple message focused on one benefit of myGeisinger: scheduling and managing appointments online Less-is-better: Email	Focused on Medical Information Access n=2350 Participants A simple message focused on one benefit of myGeisinger: accessing medical information, like test results Less-is-better: Email	Social Proof n=2350 Participants A message similar to control, but including information about how many other patients are using myGeisinger Social proof: Email	Endowment / Decision Staging n=2349 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete Endowment / decision staging: Email	Total n=14099 Participants Total of all reporting groups
Age, Categorical <=18 years	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2349 Participants	NA Participants n=14099 Participants
Age, Categorical Between 18 and 65 years	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2349 Participants	NA Participants n=14099 Participants
Age, Categorical >=65 years	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2349 Participants	NA Participants n=14099 Participants
Sex: Female, Male Female	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2349 Participants	NA Participants n=14099 Participants
Sex: Female, Male Male	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2350 Participants	NA Participants n=2349 Participants	NA Participants n=14099 Participants
Race and Ethnicity Not Collected	—	—	—	—	—	—	0 Participants Race and Ethnicity were not collected from any participant.
Region of Enrollment United States	2350 participants n=2350 Participants	2350 participants n=2350 Participants	2350 participants n=2350 Participants	2350 participants n=2350 Participants	2350 participants n=2350 Participants	2349 participants n=2349 Participants	14099 participants n=14099 Participants

PRIMARY outcome

Timeframe: 8-10 days post-intervention

Population: Patients who were delivered an email (i.e. email did not bounce back) and for whom there was a record in the EHR 10 days post-intervention.

Whether email was opened (yes / no)

Outcome measures

Measure	Control n=2117 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=6384 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=2127 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging n=2115 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Email Opened: Control vs. Less-is-better vs. Social Proof vs. Endowment	558 Participants	1528 Participants	375 Participants	488 Participants

PRIMARY outcome

Timeframe: 8-10 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 10 days post-intervention.

Whether the link / button to start the activation process was clicked (yes / no)

Outcome measures

Measure	Control n=558 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=1528 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=375 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging n=488 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Link Clicked: Control vs. Less-is-better vs. Social Proof vs. Endowment	134 Participants	160 Participants	31 Participants	73 Participants

PRIMARY outcome

Timeframe: 8-10 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 10 days post-intervention.

Whether the patient enrolled in myGeisinger (yes / no)

Outcome measures

Measure	Control n=558 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=1528 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=375 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging n=488 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Enrollment: Control vs. Less-is-better vs. Social Proof vs. Endowment	41 Participants	83 Participants	18 Participants	38 Participants

SECONDARY outcome

Timeframe: 32-35 days post-intervention

Population: Patients who were delivered an email (i.e. email did not bounce back) and for whom there was a record in the EHR 32 days post-intervention.

Whether email was opened (yes / no)

Outcome measures

Measure	Control n=2095 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=6308 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=2107 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging n=2096 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Email Opened: Control vs. Less-is-better vs. Social Proof vs. Endowment	591 Participants	1626 Participants	402 Participants	512 Participants

SECONDARY outcome

Timeframe: 32-35 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 32 days post-intervention.

Whether the link / button to start the activation process was clicked (yes / no)

Outcome measures

Measure	Control n=591 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=1626 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=402 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging n=512 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Link Clicked: Control vs. Less-is-better vs. Social Proof vs. Endowment	147 Participants	188 Participants	34 Participants	86 Participants

SECONDARY outcome

Timeframe: 32-35 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 32 days post-intervention.

Whether the patient enrolled in myGeisinger (yes / no)

Outcome measures

Measure	Control n=591 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=1626 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=402 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging n=512 Participants A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Enrollment: Control vs. Less-is-better vs. Social Proof vs. Endowment	55 Participants	152 Participants	29 Participants	55 Participants

SECONDARY outcome

Timeframe: 8-10 days post-intervention

Population: Patients who were delivered an email (i.e. email did not bounce back) and for whom there was a record in the EHR 10 days post-intervention.

Whether email was opened (yes / no)

Outcome measures

Measure	Control n=2129 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=2124 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=2131 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Email Opened: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)	524 Participants	522 Participants	482 Participants	—

SECONDARY outcome

Timeframe: 8-10 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 10 days post-intervention.

Whether the link / button to start the activation process was clicked (yes / no)

Outcome measures

Measure	Control n=524 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=522 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=482 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Link Clicked: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)	45 Participants	42 Participants	73 Participants	—

SECONDARY outcome

Timeframe: 8-10 days post-intervention

Whether the patient enrolled in myGeisinger (yes / no)

Outcome measures

Measure	Control n=524 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=522 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=482 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Enrollment: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)	24 Participants	28 Participants	31 Participants	—

SECONDARY outcome

Timeframe: 32-35 days post-intervention

Population: Patients who were delivered an email (i.e. email did not bounce back) and for whom there was a record in the EHR 32 days post-intervention.

Whether email was opened (yes / no)

Outcome measures

Measure	Control n=2107 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=2094 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=2107 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Email Opened: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)	568 Participants	554 Participants	504 Participants	—

SECONDARY outcome

Timeframe: 32-35 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 32 days post-intervention.

Whether the link / button to start the activation process was clicked (yes / no)

Outcome measures

Measure	Control n=568 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=554 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=504 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Link Clicked: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)	57 Participants	51 Participants	80 Participants	—

SECONDARY outcome

Timeframe: 32-35 days post-intervention

Population: Patients who opened the intervention email and for whom there was a record in the EHR 32 days post-intervention.

Whether the patient enrolled in myGeisinger (yes / no)

Outcome measures

Measure	Control n=568 Participants A standard marketing message encouraging activation and describing the benefits of myGeisinger	Less-is-better n=554 Participants A simple message focused on one benefit of myGeisinger.	Social Proof n=504 Participants A message similar to control, but including information about how many other patients are using myGeisinger	Endowment / Decision Staging A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate. Endowment: Give patients the impression they already have the account, so they value it more. Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete
Enrollment: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)	54 Participants	46 Participants	52 Participants	—

Adverse Events

Control

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Focused on Provider Communication

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Focused on Scheduling

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Focused on Medical Information Access

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Social Proof

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Endowment / Decision Staging

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Amir Goren, PhD

Geisinger Clinic

Phone: 5702144395

Email: agoren@geisinger.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place